Credit: Cancer Science Institute - image created with BioRender
Multispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identification of bad co-expressing cells that can predict the survival outcome of cancer patients.